Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? - Wikidata - wikimedia - TriplyDB

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

http://www.wikidata.org/entity/Q36163029

about

Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia Acute lymphoblastic leukaemia Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia Monoclonal antibodies in acute lymphoblastic leukemia Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction Asparaginase pharmacokinetics and implications of therapeutic drug monitoring Childhood acute lymphoblastic leukemia: Integrating genomics into therapy Enhancing Adolescent and Young Adult Oncology Research Within the National Clinical Trials Network: Rationale, Progress, and Emerging Strategies Prognostification of ALL by Cytogenetics Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good R Feasibility and initial effectiveness of home exercise during maintenance therapy for childhood acute lymphoblastic leukemia Incidence and survival rates of hematological malignancies in Japanese children and adolescents (2006-2010): based on registry data from the Japanese Society of Pediatric Hematology.Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan.Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia.Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia.Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.The poison oligonucleotide F10 is highly effective against acute lymphoblastic leukemia while sparing normal hematopoietic cells Cranial radiation for pediatric T-lineage acute lymphoblastic leukemia: a systematic review and meta-analysis.Low PKCα expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome.Methylenetetrahydrofolate reductase C677T and overall survival in pediatric acute lymphoblastic leukemia: a systematic review.A revised definition for cure of childhood acute lymphoblastic leukemia.A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia.Biology of childhood acute lymphoblastic leukemia.Outcome of Adolescents with Acute Lymphoblastic Leukemia Treated by Pediatrics versus Adults Protocols The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.A systematic review of dental late effects in survivors of childhood cancer Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts.Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease Early left ventricular dysfunction in children after hematopoietic stem cell transplantation for acute leukemia: a case control study using speckle tracking echocardiography.Evaluation of the in vitro and in vivo efficacy of the JAK inhibitor AZD1480 against JAK-mutated acute lymphoblastic leukemia.A systematic review of selected musculoskeletal late effects in survivors of childhood cancer.Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.

P2860

Q24310753-EE918B3A-3DE8-4B74-98F0-49C6CC6225AD Q24602387-A94D4B8A-18D9-444A-838F-87B1EC503716 Q26778780-9588A1E4-6A47-4053-A459-938B328D30ED Q26783577-D9A46FFC-540D-4106-A998-D0B590D4ED52 Q27022540-BD024805-248D-424F-B359-5C187CDA3641 Q27023839-E2F2B3F6-CA92-436F-8F58-0734D19BC4CA Q27026476-36DCF754-0038-4C1C-8873-BB67F22DCDE3 Q28080463-CB127000-6AB1-43F2-8018-2C74372B2A04 Q28086955-01BF6F3A-B7FD-42CC-B7CF-0FB516F4FEF3 Q28087446-D51A85BF-9634-4557-96DE-2142AE4C31F4 Q28540685-67AC67A3-2339-4BAC-A6BA-72417C77FB40 Q30357731-78B8A375-9EBF-4B60-8BA1-48B3A7894350 Q30596383-3C9B9760-C1D3-49F4-A9A0-C304BB0F8773 Q30631947-626CE15E-1782-4DBC-8134-10D787B6DA8A Q31170949-DA779E9D-76D1-4ADF-BB67-234E76D72AA5 Q33431558-67A89BBD-EAA9-44B4-B52A-109157C0BD29 Q33585130-E4153520-11BA-4593-B7E7-9251C74544B3 Q33586588-D1139E88-21EF-48E8-BF20-BF4A8C872024 Q33688248-DB8F2105-46D0-44E7-804A-2CD8B38368E7 Q33761600-56EE5320-1C85-4925-AD68-8802849C9CBE Q33762835-69E38FF4-0866-43A4-9313-CC01465BA646 Q33828580-4431B12C-DAD4-432F-B359-BAA32A23DFA8 Q33952803-C4B9D1F4-45FA-474E-ACC4-A82EC4E59469 Q34100901-24F6C2E0-61B9-421B-A048-E03C7119837E Q34203403-703CE665-8046-4BB9-8787-B5FC2D776A6B Q34221792-1FD446A3-2041-49A9-B877-7656DDFB9A38 Q34336668-ED4F93EE-1D46-4A9C-856A-07157D999CA8 Q34429332-871583BF-EF03-47DF-B675-3B0A5C64D69D Q34448969-DB943844-7439-4FCB-8939-0BBA73412050 Q34459885-A8FFA74B-A097-4127-BC2D-3BF3E1270A12 Q34605953-E9D2FD15-D8D5-4913-A08F-5AF66EFEBA2A Q34610024-838DDD78-FD2A-435A-87D9-F6C35EE3800D Q34798033-A3A3AEBC-19DA-4F24-92A7-C6196A5788EE Q34802494-122E3945-0A1A-4E19-AA02-A5AD36C462BB Q34979869-3AF1B24C-96B9-482E-8916-3EEEB9B071DE Q35022780-AAE4686D-18C3-47AC-AC41-986DABD140D1 Q35028620-8934C631-C24E-4BEA-8F45-9E24A0C7671F Q35079398-55B07689-A762-48FD-B59C-1399FB4F2D02 Q35108050-F666973A-147C-4505-BFDD-1C1A75ADCDF4 Q35183874-A7A3A49D-5164-4858-ABC9-E41B02875ABA

P2860

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

http://www.wikidata.org/entity/Q36163029

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@ast

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@en

type

label

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@ast

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@en

prefLabel

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@ast

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@en

P1433

Q36163029-4ACB95EE-B8A9-4C47-9402-287612B5EB16

P1476

Q36163029-D9785E63-D1CE-4686-B0A7-921ED23D9BDA

P2093

Q36163029-0FCF2FEF-2C45-482E-8982-1373ABE8E8E4

Q36163029-66C4CFC2-665C-42CC-92FD-621012958785

Q36163029-68FC8AFA-B859-4DFE-9B8B-1A57EC88F8F4

P2860

Q36163029-03BADAAD-45E9-40C7-ADFB-BA059493ED44

Q36163029-06F47B2D-3286-4889-8A76-1F55CA12D39B

Q36163029-0DB15DF8-C3BB-4D0E-8AA7-6B6B3B76BC83

Q36163029-1029BEEB-805D-4D2B-AC1D-EE6C6EAF4B6E

Q36163029-1069A5D4-5977-4FA2-82F3-FEE256BB54FB

Q36163029-14D45302-174D-4590-B640-A0D1F4B03ABB

Q36163029-17C3A617-7AB8-4C66-8D45-1B4303A27054

Q36163029-19576A9C-EAB0-4F83-B19A-0DF761A371F2

Q36163029-1B9B6C86-7EFC-45C6-AB7D-D5DA54713285

Q36163029-1C90CABE-6F2C-4E42-AE4B-B6D1358F5577

P304

Q36163029-AAA58045-72E6-4442-A923-F9DF18A6917D

P31

Q36163029-C9EC15F5-1ED3-4F3A-A9B3-4B12CD0BB8BD

P356

Q36163029-866C9856-8C58-46ED-941E-8C3BF9E81E79

P407

Q36163029-46168F62-C3C8-4C26-8508-58E6A363BC9D

P433

Q36163029-4CCA0D6A-FEE7-4E97-9ABA-0BA8783E6F99

P478

Q36163029-9E1D5B72-1B30-49BD-98FC-C21457ABD2CA

P50

Q36163029-5AFA0A12-B4FF-4128-A3C8-18295FFCDAFE

P577

Q36163029-B584F5ED-C8B2-4CE2-8C77-76695935BABB

P5875

Q36163029-F8CE1BE3-11FF-45C6-B2CF-CB3CB111B3D4

P698

Q36163029-55126914-F136-4872-BF0A-40D5AF3F6C3E

P921

Q36163029-4F47543C-FCDD-4F78-BC9A-E03113800B12

P932

Q36163029-75E4B79B-330F-462D-817C-85811BAD672F

P356

BLOOD-2012-05-378943

P1433

P1476

Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

@en

P2093

Charles G Mullighan

http://www.w3.org/2001/XMLSchema#string

Mary V Relling

http://www.w3.org/2001/XMLSchema#string

William E Evans

http://www.w3.org/2001/XMLSchema#string

P2860

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

Treating childhood acute lymphoblastic leukemia without cranial irradiation

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study

IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL.

Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia

Germline genomic variants associated with childhood acute lymphoblastic leukemia

Inactivating mutations of acetyltransferase genes in B-cell lymphoma

P304

1165-1174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2012-05-378943

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228064429

http://www.w3.org/2001/XMLSchema#string

P698

22730540

http://www.w3.org/2001/XMLSchema#string

P921

P932

3418713

http://www.w3.org/2001/XMLSchema#string